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Background. An efﬁcient indicated prevention of psychotic disorders requires valid risk criteria that work in both clin-
ical and community samples. Yet, ultra-high risk and basic symptom criteria were recently recommended for use in clin-
ical samples only. Their use in the community was discouraged for lack of knowledge about their prevalence, clinical
relevance and risk factors in non-clinical, community settings when validly assessed with the same instruments used
in the clinic.
Methods. Using semi-structured telephone interviews with established psychosis-risk instruments, we studied the
prevalence of psychosis-risk symptoms and criteria, their clinical relevance (using presence of a non-psychotic mental
disorder or of functional deﬁcits as proxy measures) and their risk factors in a random, representative young adult com-
munity sample (N=2683; age 16–40 years; response rate: 63.4%).
Results. The point-prevalence of psychosis-risk symptoms was 13.8%. As these mostly occurred too infrequent to meet
frequency requirements of psychosis-risk criteria, only 2.4% of participants met psychosis-risk criteria. A stepwise rela-
tionship underlay the association of ultra-high risk and basic symptoms with proxy measures of clinical relevance, this
being most signiﬁcant when both occurred together. In line with models of their formation, basic symptoms were selec-
tively associated with age, ultra-high risk symptoms with traumatic events and lifetime substance misuse.
Conclusions. Psychosis-risk criteria were uncommon, indicating little risk of falsely labelling individuals from the com-
munity at-risk for psychosis. Besides, both psychosis-risk symptoms and criteria seem to possess sufﬁcient clinical rele-
vance to warrant their broader attention in clinical practice, especially if ultra-high risk and basic symptoms occur
together.
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Introduction
Psychotic disorders are frequently chronic disorders
causing severe disability; thus, incurring high direct
and indirect costs and psychosocial burden (Gustavsson
et al. 2011). Oftentimes, signiﬁcant delays in the initiation
of adequate treatment contribute to poor outcome
(Penttilä et al. 2014), which are fostered by stigmatising,
negative attitudes both towards people with mental ill-
ness and towards help-seeking for mental problems
(Schnyder et al. 2017). Stigma against peoplewithmental
illness, in turn, is primarily fuelled by illness-associated
unusual behaviours that, in particular in case of psych-
oses, are perceived by others as unpredictable and dan-
gerous (Corcoran, 2016; Imhoff, 2016). Thus, a
comprehensive earlydetection of and intervention inper-
sons at increased risk for developing a psychotic disorder
may not only improve outcomes and reduce costs
(Fusar-Poli et al. 2013) butmay also reduce stigmatization
by avoiding overt psychotic symptoms and the label
‘schizophrenia’, and by providing adequate education
early on (Corcoran, 2016; Imhoff, 2016). Yet, as only few
personswithabeginningpsychosis seekhelp in their pro-
dromal phase (Schultze-Lutter et al. 2015a; Kazdin, 2017),
a comprehensive preventive approach would require
assertive community programs, incl. effective outreach
screening and awareness programs, in order to reduce
signiﬁcantly the incidence of psychosis at community
level. These, in turn, require good knowledge about the
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prevalence and clinical relevance of the presumed
psychosis-risk symptoms and criteria in the community.
The two complementary current approaches to a
psychosis-risk detection comprise: (1) the three ultra-
high risk criteria whose two symptomatic criteria
include mainly attenuated (APS) but also brief inter-
mittent psychotic symptoms (BIPS), and (2) the two
basic symptom criteria, cognitive–perceptive basic
symptoms (COPER) and cognitive disturbances
(COGDIS) that mainly include subjective cognitive dis-
turbances (Fusar-Poli et al. 2013; Schultze-Lutter et al.
2015b). Supplementary Text S1 provides details on
psychosis-risk approaches and criteria. Recently, the
European Psychiatric Association recommended the
APS and BIPS criteria and COGDIS for alternative
use in psychosis-risk detection (Schultze-Lutter et al.
2015b). The genetic risk-functional decline criterion of
the ultra-high risk approach was not recommended
for lack of evidence of a relevant risk enhancement,
COPER was not recommended for lack of research
on it. Furthermore, restricting the use of psychosis-risk
criteria to individuals distressed by mental problems
and seeking help for them was recommended. Any
clinical screening of other individuals was regarded
as not warranted by current scientiﬁc evidence for
the lack of studies outside clinical settings (Schultze-
Lutter et al. 2015b).
So far, community studies in representative samples
exclusively targeted presumed APS/BIPS, never basic
symptoms. With two exceptions (Schultze-Lutter
et al. 2014a; Schimmelmann et al. 2015), these have
never used special instruments for psychosis-risk
assessment, although some clinician-assessed
interview-studies have been conducted in selected,
often child and adolescent samples using assessments
for psychotic symptoms (Spauwen et al. 2003, 2006;
Hanssen et al. 2005; Kelleher et al. 2012a, b; Asher
et al. 2013; Nuevo et al. 2013; Jeppesen et al. 2015).
The majority of community studies on alleged psych-
otic experiences, however, was conducted with self-
report questionnaires or fully standardized layperson
interviews. From these, a median prevalence of 7.2%
of so-called ‘psychotic-like experiences’ was estimated
(Linscott & van Os, 2013). These psychotic-like experi-
ences were frequently assumed to resemble APS
(Schultze-Lutter et al. 2011, 2014b), although the
mode of assessment accounted for most of the vari-
ance (19.7%) in the observed rates, indicating a great
overestimation of psychotic-like experiences by ques-
tionnaires (Linscott & van Os, 2013; Schultze-Lutter
et al. 2014b). Additionally, beside sociodemographic
risk factors for the presence of psychotic-like experi-
ences, higher rates were also observed in convenience,
and non-dispersed and smaller samples (Linscott &
van Os, 2013).
Aims of the study
To close the gap of knowledge on psychosis-risk symp-
toms and criteria in the community when validly
assessed in accordance with their assessment in clinical
samples, we studied their point-prevalence and clinical
relevance as well as risk factors for their presence in a
large, random, representative general population sam-
ple of young adults. For the reported higher psychosis-
predictive power of the combined presence of ultra-
high risk and basic symptoms (Fusar-Poli et al. 2016),
we expected the highest clinical relevance for this com-
bination. Additionally, for their conceptualization as
the most immediate psychopathological manifestation
of neurobiological aberrations underlying psychoses
(Schultze-Lutter et al. 2016), we expected basic symp-
toms to be most strongly associated with risk factors
related to neurobiology, such as genetic vulnerability
and age.
Methods
Study design
The Bern Epidemiological At-Risk (BEAR) study used
a stratiﬁed sampling method to obtain a representative
sample of 7370 people aged 16–40 years from the
approximately 310 000 predominantly Caucasian peo-
ple of this age registered in the semi-rural Canton of
Bern, whose largest city has about 134 000 citizens;
21% of its population is non-Swiss (80% from
European countries). The age range of 16–40 years
was selected because most ﬁrst episodes of affective
and non-affective psychoses and psychotic symptoms
(interquartile range of the 25th and 75th percentiles)
are reported to occur between 17 and 41 years of age
(Kirkbride et al. 2006; McGrath et al. 2016). Stratiﬁed
by sex (1:1), potential participants were randomly
drawn from the population register including their
address, date of birth, sex, nationality, and parents’
names (for minors). Telephone numbers were subse-
quently searched in directories and the Internet. The
ethics committee of the University of Bern approved
the study; participation in the telephone interview
indicated that informed consent had been provided.
Procedure
Recruitment and assessments were conducted over 3.5
years (June 2011–November 2014) supported by the
Computer-Assisted Telephone Interviewing technique.
Prior to commencing the study, a feasibility study of
the reliability of telephone assessments of psychosis-
risk symptoms and criteria in comparison with the
gold standard of face-to-face assessments found excel-
lent concordance rates of 86–100% (Michel et al. 2014).
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To increase the response rate, the ﬁrst contact was
established by sending a one-page information letter
to potential participants and, if minors, to their
parents. The letter explained the aims of the study, vol-
untariness of participation, participation-associated
lottery, data security and anonymity, and non-report
of ﬁndings to avoid violating the ‘right not to know’
(Koponen & Aromaa, 2017). First telephone contact
was attempted within 2 weeks of sending the letter.
The lottery with monetary winnings (40–2000 CHF)
at an announced 1:50 chance of winning served as an
incentive to counteract the known bias in epidemio-
logical studies towards individuals with a higher edu-
cational background and high interest in the study’s
topic (Guyll et al. 2003).
Participants
In addition to age range and main residency (i.e. a
valid address and not being abroad during the assess-
ment period) in the Canton of Bern, an available tele-
phone number was required for eligibility. Interviews
were aborted prematurely when it became clear that
respondents had a lifetime diagnosis of psychosis or
insufﬁcient language skills in German, French,
English, or Spanish. Telephone numbers not answered
in 100 attempts made at various times and days,
including Saturdays, over several months were consid-
ered suggestive of long-time absence and, conse-
quently, of unknown eligibility.
Assessments
Assessment of psychosis-risk symptoms and criteria
Psychosis-risk symptoms and criteria (for further
details, see online Supplementary Text S1) were
assessed for lifetime presence, onset, and current fre-
quency using two semi-structured instruments for
that good interrater reliability between trained raters
has been reported (Schultze-Lutter et al. 2007;
McGlashan et al. 2010):
• The Structured Interview for Psychosis-Risk
Syndromes (McGlashan et al. 2010), a main instru-
ment for assessing ultra-high risk criteria (Schultze-
Lutter et al. 2013), in brief, deﬁnes the APS criterion
by (1) at least one of the ﬁve positive items with a
score on the seven-point Likert scale of ‘3’ (moderate)
to ‘5’ (severe but not psychotic), (2) ﬁrst occurrence or
worsening within the past 12 months, and (3) at least
weekly occurrence within the past month. The BIPS
criterion is deﬁned by (1) at least one of these ﬁve
positive items with a score of ‘6’ (severe and psych-
otic), which (2) was reached within the past 3 months
and (3) was present at least for several minutes per
day at a frequency of at least once per month. APS
and BIPS were only rated if the phenomenon in ques-
tion was not fully and better explained by another
non-psychotic disorder or an effect of psychotropic
drug use (McGlashan et al. 2010; Schultze-Lutter
et al. 2013).
The genetic risk-functional decline criterion was
estimated only with a ﬁrst-degree relative of psych-
osis serving as a genetic risk factor and being
assessed with the Structured Interview for
Psychosis-Risk Syndromes; schizotypal personality
disorder was not assessed because of the lack of
an informant (Tyrer et al. 2007).
• The Schizophrenia Proneness Instrument, Adult ver-
sion (Schultze-Lutter et al. 2007), used for assessing
basic symptom criteria in adults deﬁnes COPER by
(1) at least one of ten basic symptoms with (2) ﬁrst
occurrence at least 12 months ago and (3) an occur-
rence of at least ‘several times in a month or weekly’
within the past 3 months (Schultze-Lutter et al.
2015b). COGDIS requires (1) at least any two of
nine cognitive basic symptoms of that ﬁve are also
included in COPER with (2) an occurrence of at
least ‘several times in a month or weekly’ within
the past 3 months (Schultze-Lutter et al. 2015b).
Strictly, the deﬁnition of basic symptoms includes
the requirement that the phenomenon in question
presents a deviation from the ‘normal’ self.
Nevertheless, to allow the rating of lifelong persistent
complaints, the Schizophrenia Proneness Instrument,
Adult version also includes a rating of ‘7’, ‘has always
been present in the same severity (trait)’.
Assessment of mental disorders
ThepresenceofDSM-IVaxis-Idisorders,whichcanbeval-
idly assessed on the telephone (Rohde et al. 1997), was
assessed using the Mini-International Neuropsychiatric
Interview (Sheehan et al. 1998). In combination with the
Structured Interview of Psychosis-Risk Syndromes, it
was also used to assess past and present psychoses
and their type as part of the exclusion criteria (for details
on this group see Michel et al. 2016). Requiring about
25% of the assessment time of other scales for the
assessment of axis-I disorders, the Mini-International
Neuropsychiatric Interview possesses good construct
validitywithotherestablishedscales andexpertdiagnoses
as well as good interrater and retest reliability (Sheehan
et al. 1998). Furthermore, it has been successfully applied
in telephone interviews with non-clinical samples (Wang
et al. 2006).
Assessment of functioning
Psychosocial functioning was estimated using the
Social and Occupational Functioning Assessment
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Scale (APA, 1994). A score 470 was regarded as
indicative of a functional deﬁcit (Schimmelmann
et al. 2015).
Quality assurance
To achieve a 595% concordance rate with the trainers
(F.S.-L. and C.M.), interviewers (all clinical psycholo-
gists) received intensive 3-month training, especially
in the semi-structured context-dependent personalized
assessment of psychosis-risk symptoms and mental
disorders. In line with clinical assessments, this rou-
tinely included gathering thorough information on:
• situations in that the phenomenon had occurred,
• the degree of externalization / conviction,
• participant’s reaction in response to / explanation of
the potential symptom incl. distress,
• reactions of others (in particular, others’ opinion on
potential ‘unusual thought content’ to control for
‘normal’ subcultural believes),
• potential associations with substance use, somatic /
known neurological conditions or hypnagogic/
hypnopompic states.
Additionally, weekly supervisions of all symptom
ratings in case of conferences with the interviewers
on the basis of all available information performed
by either of two very experienced experts in the early
detection of psychosis (F.S.-L. or C.M.) ensured excel-
lent, valid and reliable data quality.
Statistical analyses
Using Statistical Package for Social Sciences v23, the
frequencies and percentages were compared using χ2
tests and non-normally distributed continuous and
ordinal data using Mann–Whitney U tests and the
respective effect sizes. The associations of functioning
and mental disorder, as well as of the potential risk fac-
tors with current psychosis-risk symptoms and criteria
were explored by binary and multinomial regression
analyses using the Omnibus test as a goodness-of-ﬁt
measure. Stepwise regression analyses were performed
forward and backward to test for the model stability.
Results
Recruitment and representativeness of sample
Of the initial sample (N = 7370), 4471 were eligible
(Fig. 1). The contact rate was 94.8% and the response
rate 63.4%. Of the 2857 interviews, 125 (4.4%) were
aborted prematurely by interviewers for insufﬁcient
language skills and 41 (1.4%) for lifetime psychosis
(Michel et al. 2016). Only eight (0.6%) participants ter-
minated the interview of their own accord; 2683
Fig. 1. Results of recruitment. Survey outcome rates of the BEAR study according to the deﬁnitions of the American
Association for Public Opinion Research (AAPOR, 2016).
4 Frauke Schultze-Lutter et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291717002586
Downloaded from https://www.cambridge.org/core. Universitätsbibliothek Bern, on 07 Mar 2018 at 13:10:46, subject to the Cambridge Core terms of use, available at
(93.9%) interviews were completed, which took 43 min
on average (standard deviation: 20 min). Almost all
participants considered the interview as very or rather
pleasant (97.9%) and not stressful (97.5%); 97.9%
agreed to be re-contacted for a similar interview
in future.
The eligible sample was slightly older than the 16- to
40-year-old general population of Bern, with an
extremely small effect size of d = 0.053. Yet, no age
group was signiﬁcantly over- or underrepresented
(Table 1).
The main reasons for refusal were a lack of interest
or time (online Supplementary Table S2). Participants
differed marginally from refusers in age, sex, and
Swiss nationality; all differences were of extremely
small effect size (Table 1). More interviews with
non-Swiss individuals were aborted for language-
related reasons. Additionally, participants who com-
pleted the interviews were slightly older than those
who aborted interviews (Table 1). Similar to the obser-
vation in the eligibility sample, the 2683 participants
differed marginally from the 16- to 40-year-old general
population of Bern in mean age, but not in distribution
across age groups, sex, nationality, or marital status
(Table 1). Thus, as no response bias was detectable
beyond the negligible age-related inclusion bias, parti-
cipants were well representative of their age group.
Their sample characteristics are provided online in
Supplementary Table S3.
Prevalence of psychosis-risk symptoms and criteria
In total 659 (24.6%) participants reported at least one
lifetime psychosis-risk phenomenon; 460 (17.1%) had
experienced one around the time of the interview.
When trait-like phenomena (reported as always having
been present at the same frequency and severity and,
consequently, strictly not meeting the general require-
ment for a change in mental state) were excluded, the
numbers went down to 567 (21.1%) for lifetime and
370 (13.8%) for current psychosis-risk symptoms
(Table 2). Table 2 provides the prevalence rates of sin-
gle symptoms.
When the onset and frequency requirements of the
psychosis-risk criteria were considered, altogether 64
(2.4%) participants met at least one criterion, most fre-
quently COPER (n = 52, 1.94%; n = 15, 0.39%, exclu-
sively) and never the genetic risk-functional decline
criterion (Fig. 2). Only 29 (1.08%) met psychosis-risk cri-
teria recommended by the European Psychiatric
Association, i.e., APS, BIPS and/or COGDIS (Schultze-
Lutter et al. 2015b). Five participants (0.19%) who met
the APS criterion also met COPER and/or COGDIS
(Fig. 2).
Clinical relevance of psychosis-risk symptoms and
criteria
Excluding trait-like phenomena, the presence of any
current psychosis-risk symptom and any psychosis-
risk criterion signiﬁcantly predicted both the presence
of any mental disorder and, more strongly, the pres-
ence of a functional deﬁcit (Table 3). Taking into
account the differential effects of APS/BIPS and basic
symptoms, odds ratios (ORs) indicated the expected
stepwise increase in the effects where the effect of the
combined presence of ‘ultra-high risk and basic symp-
toms’was the strongest on both symptom and criterion
level (Table 3).
Risk factors for presence of psychosis-risk symptoms
The presence of any current non-trait-like psychosis-
risk symptom was predicted by younger age, lifetime
alcohol misuse, lifetime and current drug misuse, sin-
gle marital status, no current partner, lower school
education, unemployment, family history of mental
disorders in ﬁrst- or second-degree biological relatives
(in particular of substance use and/or affective dis-
order), and lifetime traumatic events (Table 4). Sex,
migrant status (estimated by non-Swiss nationality),
minority status, current alcohol misuse, and higher
population density did not predict the presence of
any psychosis-risk symptom (Table 4). Stepwise ana-
lyses revealed a stable signiﬁcant model (goodness-
of-ﬁt: χ2(7) = 72.048, p<0.001) including younger age,
lifetime drug misuse, no current partner, lower school
education, unemployment, family history of mental
disorders, and lifetime traumatic event as the
predictors of any current psychosis-risk symptom
(Table 4).
When ultra-high risk and basic symptoms were dis-
tinguished (online Supplementary Table S4), the fol-
lowing predictors of psychosis-risk symptom
constellations emerged:
• exclusively ultra-high risk symptoms: family history
of mental disorders, lifetime trauma, lifetime alcohol
and lifetime drug misuse, unemployment, and no
current partner;
• exclusively basic symptoms: family history of men-
tal disorders, younger age, unemployment, no cur-
rent partner, and single marital status;
• ultra-high risk and basic symptoms combined: fam-
ily history of mental disorders, female sex, less
school education, both lifetime and current alcohol
and drug misuse, younger age, and lifetime trauma.
No variable exclusively predicted the presence of
APS/BIPS alone. Urbanicity and both migrant and
minority status were unrelated to psychosis-risk symp-
toms (online Supplementary Table S4).
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Table 1. Estimations of the representativeness of the study sample at various levels of recruitment
Comparison of the eligible sample with the Canton Bern general population according to the Swiss Statistics Web site for 2014,
maintained by the Federal Statistical Ofﬁce (http://www.bfs.admin.ch)
Canton Bern
(N = 3 10 708)
Eligible sample
(N = 4 471)
Statisticsa
Age (mean ± standard deviation) 27.1 ± 7.1 years 30.3 ± 7.2 years t(315177) = 29.916,
p < 0.001, d = 0.053
Age ranges (%)
16–20 years 16.9 14.6 χ2(1) = 0.168, p = 0.682, w < 0.001
21–25 years 19.4 16.7 χ2(1) = 0.202, p = 0.653, w < 0.001
26–30 years 21.0 12.5 χ2(1) = 2.157, p = 0.142, w = 0.003
31–35 years 21.8 21.4 χ2(1) = 0.004, p = 0.950, w < 0.001
36–40 years 20.9 34.6 χ2(1) = 3.382, p = 0.066, w = 0.003
Sex; % male 50.3 55.6 χ2(1) = 0.265, p = 0.607, w < 0.001
Nationality; % Swiss 78.8 91.6 χ2(1) = 0.962, p = 0.327, w= 0.002
Comparison of the participants and refusers
Participants (N = 2857) Refusers (N = 1350) Statisticsb
Age (mean ± standard deviation) 30.3 ± 7.5 years 30.9 ± 7.4 years U = 1 832 908.5 p = 0.009, r = 0.040
Sex; % male 54.1 57.6 χ2(1) = 4.678, p = 0.031, V = 0.033
b
Nationality; % Swiss 91.1 92.2 χ2(1) = 3.946, p = 0.047, V = 0.031
b
Comparison of the persons with a complete and a partial interview
Complete (N = 2683) Partial (N = 174) Statisticsb
Age (mean ± standard deviation) 30.2 ± 7.6 years 32.1 ± 6.3 years U = 205 488.0, p = 0.008, r = 0.050
Sex; % male 54.0 55.7 χ2(1) = 0.208, p = 0.648, V = 0.009
Nationality; % Swiss 93.6 51.7c χ2(1) = 352.948, p < 0.001, V = 0.351
Comparison of participants with a complete interview with the Canton Bern general population according to the Swiss Statistics
Web site for 2014, maintained by the Federal Statistical Ofﬁce
Canton Bern (N = 3 10 708) Complete (N = 2 683) Statisticsa
Age (mean ± standard deviation) 27.1 ± 7.1 years 30.2 ± 7.6 years t(313389) = 22.505, p < 0.001, d = 0.040
Age ranges (%)
16–20 years 16.9 16.1 χ2(1) = 0.019, p = 0.890, w < 0.001
21–25 years 19.4 16.5 χ2(1) = 0.234, p = 0.629, w < 0.001
26–30 years 21.0 11.5 χ2(1) = 2.777, p = 0.096, w = 0.003
31–35 years 21.8 20.9 χ2(1) = 0.019, p = 0.890, w < 0.001
36–40 years 20.9 34.9 χ2(1) = 3.513, p = 0.061, w = 0.003
Sex; % male 50.3 54.0 χ2(1) = 0.131, p = 0.717, w < 0.001
Nationality; % Swiss 78.8 93.6 χ2(1) = 1.271, p = 0.260, w = 0.002
Marital status (%)
Single 66.9 55.9 χ2(1) = 0.985, p = 0.321, w = 0.002
Married/cohabitation 30.4 40.4 χ2(1) = 1.412, p = 0.235, w = 0.002
Separated/divorced/widowed 2.7 3.7 χ2(1) = 0.156, p = 0.693, w < 0.001
a Effect sizes were Cohen’s d for the t test and the effect size index, w, for the one-dimensional χ2-tests.
b Effect sizes were Rosenthal’s r for the Mann–Whitney U test and Cramer’s V for χ2-tests.
For Cohen’s d, d = 0.2 equals a small effect, d = 0.5 a medium effect, and d = 0.8 a large effect; for the effect size index w,
Rosenthal’s r and Cramer’s V, 0.1 equals a small effect, 0.3 a medium effect, and 0.5 a large effect.
c Includes 125 (71.8%) participants with whom the interview has to be terminated prematurely for language reasons,
all naturally non-Swiss participants.
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Risk factors for presence of psychosis-risk criteria
The presence of any psychosis-risk criterion was pre-
dicted by a family history of mental disorder, lifetime
drug misuse, lifetime traumatic event, and urbanicity.
Age, sex, minority or migrant status, school education,
unemployment, single marital status, current partner,
lifetime and current alcohol misuse, or current drug
misuse did not predict psychosis-risk criteria
(Table 5). All four main predictors were selected for
and remained in the stepwise model, although
Table 2. Prevalence of psychosis-risk symptoms, lifetime and current as well as lifetime and current excluding trait-like phenomena (No., % of
whole sample, N = 2683)
Lifetime
(n = 659)
Current
(n = 460)
lifetime, excl.
traits (n = 567)
Current, excl.
traits (n = 370)
Ultra-high risk symptoms
unusual thought content/delusional ideas (P1)
APS (score 3–5)z 134 (5.0) 93 (3.5) 105 (3.9) 68 (2.5)
BIPS (score 6) 1 (0.04) 1 (0.04) 0 0
suspiciousness/persecutory ideas (P2)
APS (score 3–5) 55 (2.0) 45 (1.7) 44 (1.6) 36 (1.3)
BIPS (score 6) 0 0 0 0
Grandiosity (P3)
APS (score 3–5) 8 (0.3) 6 (0.2) 6 (0.2) 4 (0.1)
BIPS (score 6) 0 0 0 0
Perceptual abnormalities/hallucinations (P4)
APS (score 3–5) 198 (7.4) 87 (3.2) 163 (6.1) 68 (2.5)
BIPS (score 6) 9 (0.34) 2 (0.08) 9 (0.34) 2 (0.08)
Disorganized communication (P5)
APS (score 3–5) 19 (0.7) 19 (0.7) a a
BIPS (score 6) 0 0 0 0
Any one APS 316 (11.8) 200 (7.5) 265 (9.9) 154 (5.7)
Any one BIPS 10 (0.37) 3 (0.11) 9 (0.34) 2 (0.08)
Basic symptoms
Thought interference 31 (1.1) b 22 (0.8) 12 (0.4)
Thought blockages 112 (4.2) b 91 (3.4) 65 (2.4)
Thought pressure 46 (1.7) b 42 (1.6) 28 (1.0)
Thought perseveration 11 (0.4) b 7 (0.3) 3 (0.1)
Disturbance of receptive speech 6 (0.2) b 5 (0.2) 4 (0.1)
Disturbance of expressive speech 55 (2.1) b 47 (1.8) 42 (1.6)
Disturbances of abstract thinking 18 (0.6) b 12 (0.4) 4 (0.1)
Inability to divide attention 22 (0.8) b 10 (0.4) 7 (0.3)
Captivation of attention, etc. 42 (1.6) b 32 (1.2) 17 (0.6)
Unstable ideas of reference 99 (3.7) b 85 (3.2) 39 (1.5)
Derealization 56 (2.1) b 51 (1.9) 22 (0.8)
Decreased ability to discriminate between ideas and perception, etc. 27 (1.0) b 23 (0.9) 13 (0.5)
Visual perception disturbances 104 (3.9) b 89 (3.3) 49 (1.8)
Acoustic perception disturbances 107 (4.0) b 99 (3.7) 52 (1.9)
Any one basic symptom 478 (17.8) b 413 (15.4) 264 (9.8)
Any one COPER symptom 416 (15.5) b 369 (13.8) 222 (8.3)
Any one COGDIS symptom 320 (11.9) b 263 (9.8) 169 (6.3)
APS: attenuated psychotic symptom; BIPS: brief intermittent psychotic symptom; COPER: ‘cognitive–perceptive basic symp-
toms’, COGDIS: ‘cognitive disturbances’.
a No information because of the primarily observation-based rating of communication during the interview and the lack of
an informant report on any potential change in the participant’s communication style.
b No information for basic symptoms, because basic symptoms (per deﬁnition a change in mental processes and, conse-
quently, no trait) reported to occur in a trait-like manner were not assessed for current frequency (0 = not present in last 3
months to 6 = daily).
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urbanicity exerted an extremely low effect (OR: 1.000,
95% CI: 1.000–1.001) (Table 5).
Discussion
An efﬁcient indicated prevention of mental disorders
requires valid risk criteria that work in both clinical
and community samples. In the case of psychotic dis-
orders, risk criteria are available that were recom-
mended for use in clinical samples but not for use in
the community for lack of knowledge about their
prevalence and clinical relevance in non-clinical set-
tings (Schultze-Lutter et al. 2015b).
Prevalence of psychosis-risk symptoms and criteria
Ultra-high risk symptoms and criteria
Community studies of psychotic-like experiences
found a median prevalence of 7.2% (range: 0.5%–
47.2%) with higher rates in convenience, non-
dispersed, and smaller samples (Linscott & van Os,
2013). Psychotic-like experiences were frequently
assumed to resemble APS or even the APS criterion
(Schultze-Lutter et al. 2011, 2014b), although their val-
idity was not sufﬁciently assured and the onset and
frequency requirements of the APS criterion were com-
monly not assessed. Thus, recent reviews and studies
indicated signiﬁcant overestimation of APS/BIPS by
and little content validity of questionnaire-assessed
psychotic-like experiences compared with the gold
standard of the assessment of APS/BIPS in a (clinical)
interview (Linscott & van Os, 2013; Schultze-Lutter
et al. 2014b). To avoid such an overestimation, we
assessed a large randomly selected, dispersed, repre-
sentative community sample of 16- to 40-year-old indi-
viduals with semi-structured clinical interviews
speciﬁcally designed for the assessment of psychosis-
risk symptoms and criteria. Hence, unsurprisingly,
the 6% prevalence rate of current APS/BIPS that were
reported as a change from earlier thought contents
and perceptions as well as the 0.6% prevalence rate
of APS/BIPS criteria were below the reported median
rate of psychotic-like experiences. Furthermore, the
prevalence rate of current APS/BIPS was in line with
the 5.8% lifetime prevalence of psychotic symptoms
reported in the World Mental Health Survey
(McGrath et al. 2016).
Basic symptoms and basic symptom criteria
For basic symptoms and related criteria, community
studies have not been performed. Thus, their preva-
lence rates of almost 10% for any current basic symp-
tom and 2% for any basic symptom criterion, mainly
Fig. 2. Distribution of psychosis-risk criteria (n = 64). APS: attenuated psychotic symptoms criterion; BIPS: brief intermittent
psychotic symptoms criterion; COPER: cognitive–perceptive basic symptoms criterion; COGDIS: cognitive disturbances
criterion. For detailed descriptions of criteria, see online Supplementary Text S1.
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by COPER, cannot be compared with other ﬁndings.
The higher prevalence of COPER compared with
COGDIS, however, is in line with ﬁndings in clinical
samples that found COPER to be more sensitive and
COGDIS more speciﬁc (Schultze-Lutter et al. 2012).
Any psychosis-risk symptom and criterion
Overall, 14% of participants reported current
psychosis-risk symptoms as a change in mental pro-
cesses or experiences. Psychosis-risk symptoms
occurred mainly infrequent; consequently, psychosis-
risk criteria were met by a mere 2.4%, reaching as
low as 1.1% if only psychosis-risk criteria recom-
mended by the European Psychiatric Association
were considered, i.e. APS, BIPS, and/or COGDIS
(Schultze-Lutter et al. 2015b). Thus, if added to the
1.4% rate of participants excluded for past or present
psychoses (Michel et al. 2016), the point-prevalence of
participants considered at clinical high-risk for psych-
osis is as high—or even slightly lower—as that
expected from the reported lifetime prevalence of
any non-organic psychotic disorder of 3.5% (Perälä
et al. 2007).
Clinical signiﬁcance of psychosis-risk symptoms and
criteria
Irrespective of their potential association with the
future development of a psychotic disorder, the pres-
ence of any psychosis-risk symptom and, more
strongly, of any psychosis-risk criterion, was associated
Table 3. Association of current psychosis-risk symptoms, excl. trait-like symptoms, and psychosis-risk criteria (entering as binary and
multinomial variable, respectively) with presence of any non-psychotic axis-I DSM-IV disorder (n = 351) and presence of a functional deﬁcit
(SOFAS470; n = 147)
β
Standard
error Wald df
p
valuea
Odds
ratio
95%
lower
CI
upper
Presence of any non-psychotic mental
disorder (N = 351)
Any psychosis-risk symptomb (n = 114) 1.361 0.132 10.607 1 < 0.001 3.901 3.013 5.051
Psychosis-risk symptomsb,c 117.007 3 <0.001
Only basic symptoms (n = 54) 1.072 0.171 39.063 1 <0.001 2.920 2.087 4.086
Only APS/BIPS (n = 38) 1.588 0.214 55.168 1 <0.001 4.895 3.219 7.443
Both (n = 22) 2.003 0.298 45.277 1 <0.001 7.412 4.136 13.284
Any psychosis-risk criterionb (n = 29) 1.777 0.258 47.404 1 <0.001 5.911 3.564 9.802
Psychosis-risk criteria,c,d 46.204 3 <0.001
Only COPER/COGDIS (n = 21) 1.677 0.295 32.377 1 <0.001 5.350 3.002 9.534
Only APS/BIPS (n = 4) 1.559 0.648 5.787 1 0.016 4.756 1.335 16.943
Both (n = 4) 3.351 1.120 8.959 1 0.003 28.534 3.179 256.085
Presence of a functional deﬁcit (N = 147)
Any psychosis-risk symptomb (n = 71) 1.948 0.176 122.200 1 <0.001 7.013 4.965 9.905
Psychosis-risk symptomsb,c 148.719 3 <0.001
Only basic symptoms (n = 26) 1.399 0.239 34.099 1 <0.001 4.049 2.532 6.475
Only APS/BIPS (n = 27) 2.309 0.252 84.192 1 <0.001 10.060 6.144 16.472
Both (n = 18) 2.871 0.320 80.439 1 <0.001 17.661 9.430 33.076
Any psychosis-risk criterionb (n = 29) 2.865 0.268 114.141 1 <0.001 17.554 10.378 29.695
Psychosis-risk criteria,c,e 113.698 3 <0.001
Only COPER/COGDIS (n = 21) 2.766 0.304 82.954 1 <0.001 15.890 8.763 28.813
Only APS/BIPS (n = 5) 3.053 0.639 22.802 1 <0.001 21.186 6.050 74.190
Both (n = 3) 3.459 0.918 14.205 1 <0.001 31.780 5.260 192.005
Results of univariate logistic regression analyses.
APS, attenuated psychotic symptom; BIPS, brief intermittent psychotic symptom; COPER, cognitive–perceptive basic symp-
toms; COGDIS, cognitive disturbances; CI, conﬁdence interval of odds ratio.
All models were highly signiﬁcant with a goodness-of-ﬁt of χ2(1)541.075, p<0.001.
aWhen adjusting for multiple testing (four tests in each domain), the critical p value of each test is 0.0125.
b Correct prediction of absence of mental disorder/functional deﬁcit: 100%; correct prediction of respective presence: 0%.
c Absence of any psychosis-risk symptom or criterion served as reference value.
d Correct prediction of absence of mental disorder: 100%; correct prediction of presence of mental disorder: 1.1%.
e Correct prediction of absence of functional deﬁcit: 99.7%; correct prediction of presence of functional deﬁcit: 5.4%.
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with a signiﬁcant 4- to 17-fold increased odds of current
mental disorder and current functional deﬁcit, respect-
ively, indicating their clinical relevance. Expectantly,
the association of the type of psychosis-risk symptoms
and criteria with mental illness and functional deﬁcits
demonstrated a stepwise effect. The combined presence
of ultra-high risk and basic symptoms and criteria were
the most strongly related and, with one exception, basic
symptoms and related criteria were signiﬁcantly but
least strongly associated with mental disorder and
functional impairment. Interestingly, the association
of psychosis-risk symptoms and criteria with a func-
tional deﬁcit was commonly stronger than that with a
mental disorder, indicating that psychosis-risk symp-
toms and criteria are not merely a manifestation of
mental ill-health.
Risk factors for presence of any psychosis-risk
symptom and criterion
In community studies of psychotic-like experiences,
risk factors for their presence were younger age, minor-
ity status, lower income, single marital status, sub-
stance misuse, exposure to stressful or traumatic
events, and family history of mental illness, while
there was no evidence that sex, migrant status, educa-
tion, unemployment, or urbanicity increased odds of
their report (Linscott & van Os, 2013). All but minority
status were also related to the presence of psychosis-
risk symptoms in our study, which was additionally
predicted by lower education and unemployment.
However, ORs were commonly small, ranging from
1.35 for single marital status to 2.64 for current drug
Table 4. Association of current non-trait-like psychosis-risk symptoms with predictors described for psychotic-like experiences, assessed by
questionnaires or fully-standardized lay-person interviews for psychotic symptoms in the community (Linscott & van Os, 2013) (N = 2683)
Results of univariate logistic regression analyses
β
Standard
error
Wald
(df = 1)
p
value
Odds
ratio
95%
lower
CI
upper
Agea (in years) −0.027 0.007 13.810 <0.001 0.973 0.959 0.987
Male sexb −0.183 0.112 2.666 0.103 0.833 0.669 1.037
School educationa −0.162 0.076 4.521 0.033 0.851 0.733 0.987
Current unemploymenta 0.801 0.296 7.330 0.007 2.227 1.247 3.977
Migrant statusb −0.170 0.218 0.613 0.434 0.843 0.551 1.292
Minority statusb 0.636 0.469 1.843 0.175 1.890 0.754 4.737
Single marital statusa 0.303 0.115 6.937 0.008 1.354 1.081 1.696
No current partnera 0.426 0.118 12.977 <0.001 1.531 1.214 1.931
Family history of mental disordersa,c 0.486 0.113 18.576 <0.001 1.626 1.303 2.028
Lifetime traumatic eventa 0.599 0.158 14.418 <0.001 1.820 1.336 2.479
Lifetime alcohol misusea 0.635 0.239 7.052 0.008 1.887 1.181 3.016
Current alcohol misuseb 0.665 0.408 2.651 0.103 1.944 0.873 4.327
Lifetime drug misusea 0.634 0.177 12.775 <0.001 1.885 1.332 2.669
Current drug misusea 0.971 0.348 7.785 0.005 2.640 1.335 5.221
Population density (person/km2)b 0.000 0.000 0.999 0.317 1.000 1.000 1.000
Results of stepwise logistic regression analyses
(Wald method, forward and backward)
Age −0.250 0.008 9.205 0.002 0.975 0.960 0.991
School education −0.186 0.078 5.707 0.017 0.830 0.712 0.967
Current unemployment 0.637 0.304 4.380 0.036 1.890 1.041 3.432
No current partner 0.316 0.132 5.688 0.017 1.372 1.058 1.778
Family history of mental disorders 0.562 0.117 23.091 <0.001 1.754 1.395 2.206
Lifetime traumatic event 0.505 0.162 9.672 0.002 1.657 1.205 2.278
Lifetime drug misuse 0.505 0.182 7.692 0.006 1.658 1.160 2.369
CI, conﬁdence interval of odds ratio.
a All models were signiﬁcant with a goodness-of-ﬁt of χ2(1)54.589, p<0.005.
b All models were non-signiﬁcant with a goodness-of-ﬁt of χ2(1)42.664, p>0.103.
c Any ﬁrst- or second-degree biological relative with a mental disorder reported by the interviewee in the Structured
Interview for Psychosis-Risk Syndromes.
Signiﬁcant variables at a p-level of 5% in univariate analyses are displayed in Italics.
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misuse in univariate analyses and were below 2 in the
multivariate model.
Moderate inﬂuences of sex, age, and, largely explained
by age, education years on APS/BIPS have also been
reported from a Swiss patient sample (Theodoridou
et al. 2017). Moreover, a recent review on the impact of
cannabis as the most commonly used drug reinforced
its role in the development of psychotic and schizotypal
symptoms, with family history and traumatic events
likely increasing sensitivity to cannabis (Løberg et al.
2014). Supporting these ﬁndings, the presence of any
psychosis-risk criterion was related to a history of a
ﬁrst- or second-degree relativewithmental disorder, life-
time drug misuse, and lifetime traumatic event. In this,
the effect ofapositive familyhistorywasprimarilydriven
by the reports of depressive disorders in familymembers
(in 37% of individuals with a psychosis-risk criterion).
Reportedpsychoticdisorders of relativeswerenot signiﬁ-
cantly related to psychosis-risk criteria (in 6% of indivi-
duals with a psychosis-risk criterion) or any type of
psychosis-risk symptoms. A higher rate of family
members with a depressive disorder (57%) compared
with a psychotic disorder (11%) was also reported in an
adolescent ultra-high risk sample (Simeonova et al. 2015).
In line with the ﬁndings on psychotic-like experiences
(Linscott & van Os, 2013) but contrary to the ﬁndings
on psychosis (Vassos et al. 2012), the statistically signiﬁ-
cant effect of urbanicity on psychosis-risk criteria was
negligible in our semi-rural recruitment area with
Nidau (n = 28) showing the highest population density
of 4480 individuals/km2 and Ostermundigen (n = 26)
the second highest (2643 individuals/km2). By compari-
son, Greater London’s population density is reported as
5518 individuals/km2 (source: Wikipedia). Thus, a stron-
ger effect ofurbanicitymight have beenmisseddue to the
lack of high urbanicity levels.
Differential risk factors for presence of ultra-high
risk or basic symptom and related criteria
Whensymptomsof theultra-highriskandbasic symptom
approach were considered separately, the moderators
Table 5. Association of presence of any psychosis-risk criterion with predictors described for psychotic-like experiences, assessed by
questionnaires or fully-standardized lay-person interviews for psychotic symptoms in the community (Linscott & van Os, 2013)
β
Standard
error
Wald
(df = 1)
p
value
Odds
ratio
95%
lower
CI
upper
Results of univariate logistic regression analyses
Agea −0.023 0.016 2.031 0.154 0.977 0.946 1.009
Male sexa −0.419 0.255 2.699 0.100 0.658 0.399 1.084
School educationa −0.089 0.171 0.271 0.602 0.915 0.655 1.279
Current unemploymenta −0.758 0.606 1.565 0.211 0.469 0.143 1.536
Migrant statusa 0.225 0.473 0.227 0.634 1.252 0.496 3.162
Minority statusa 0.499 1.028 0.236 0.627 1.647 0.220 12.345
Single marital statusa 0.494 0.269 3.363 0.067 1.638 0.967 2.776
No current partnera −0.453 0.262 2.996 0.083 0.636 0.380 1.062
Family history of mental disorderb 0.783 0.258 9.228 0.002 2.188 1.320 3.626
Lifetime traumatic eventb 1.077 0.296 13.249 <0.001 2.935 1.644 5.241
Lifetime alcohol misusea 0.498 0.526 0.895 0.344 1.645 0.587 4.614
Current alcohol misusea 0.959 0.740 1.677 0.195 2.608 0.611 11.124
Lifetime drug misuseb 1.153 0.319 13.031 <0.001 3.169 1.694 5.927
Current drug misusea 0.758 0.736 1.060 0.303 2.134 0.504 9.035
Population density (person/km2)b 0.000 0.000 7.427 0.006 1.000 1.000 1.001
Results of stepwise logistic regression analyses
(Wald method, forward and backward)c
Positive family history 0.697 0.260 7.175 0.007 2.007 1.206 3.341
Lifetime drug misuse 0.938 0.328 8.189 0.004 2.555 1.344 4.858
Lifetime traumatic event 0.884 0.308 8.257 0.004 2.421 1.325 4.424
Population density 0.000 0.000 5.595 0.018 1.000 1.000 1.001
CI, conﬁdence interval of odds ratio.
a All models were non-signiﬁcant with a goodness-of-ﬁt of χ2(1)43.521, p>0.061.
b All models were signiﬁcant with a goodness-of-ﬁt of χ2(1)56.650, p<0.010.
c The model was highly signiﬁcant with a goodness-of-ﬁt of χ2(4) = 31 175, p<0.001; correct classiﬁcation of risk-negative cases:
100%, correct classiﬁcation of risk-positive cases: 0%.
Signiﬁcant variables at a p-level of 5% in univariate analyses are displayed in Italics.
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differedgreatly. In linewithourexpectations,youngerage
was selectively related to basic symptoms, supporting the
earlier notion that APS might be more common but less
clinically relevant and predictive of psychosis below the
age of 15/16 years (Cornblatt et al. 2015; Schimmelmann
et al. 2015). The age effect on the basic symptoms groups,
however, might indicate a potentially higher age thresh-
old for basic symptoms that still works within this sam-
ple’s age range, possibly because of the brain maturation
processes still ongoing in the younger age segment
(Schultze-Lutter et al. 2012, 2016).
The likelihood of the presence of APS/BIPS was
selectively increased by reports of traumatic events,
as well as lifetime misuse of either alcohol or drugs.
This supports models of APS/BIPS relating their evolu-
tion to dysfunctional coping with stressors, including
the development of inadequate explanatory models
(Bentall et al. 2007; Gebhardt et al. 2008).
Strengths and limitations
To our knowledge, this is the ﬁrst study to examine val-
idly the prevalence of all relevant psychosis-risk symp-
toms and criteria in a large random community
sample of the age segment at highest risk of psychosis
(Kirkbride et al. 2006) in amanner comparablewith clin-
ical assessment. Prior to commencing the study, we
found that telephone interviews were a reliable method
of validly assessing psychosis-risk symptoms (Michel
et al. 2014). Hence, telephone interviews were selected
over face-to-face interviews for their lower costs and
assumed better response rate (e.g. less time spent travel-
ling for interviewers and participants). However, the
availability of telephone numbers was slightly asso-
ciated with older age; yet, this selection bias was so
small that it did not introduce a signiﬁcant difference
in the distribution of participants across age groups.
The potential age bias is therefore at most a negligible
limitation of our study. Thus, at a sufﬁciently large
response rate of 63% andwith nomeaningful difference
between participants and the population statistics, our
sample can be regarded as representative of the young
adult population of the Canton of Bern.
We had assumed the failure of contact attempts of
>100 as indicative of prolonged absence and, conse-
quently, ineligibility. This could have introduced a
selection bias, as psychosis-risk symptoms might be
more prevalent in hard-to-reach individuals.
However, such a bias is unlikely as the number of
attempts before the interview was unrelated to the
presence of psychosis-risk symptoms (OR: 0.994; 95%
CI: 0.986–1.003).
Beside the above-discussed possible area bias on the
effect of urbanicity, a language-related bias toward not
including individuals with migration/minority status
was detected that our study shares with several mental
health studies (Brown et al. 2014). This was despite our
efforts to minimise this bias by conducting interviews
in four different languages including those commonly
spoken in African and South-American countries. This
bias might have led to an underestimation of the inﬂu-
ence of minority status in particular that was related to
a 3–6 times increased likelihood of presenting with
psychosis (Bosqui et al. 2014).
Different effects of potential moderators might have
also been observed had we analysed them with respect
to lifetime and not only current psychosis-risk symp-
toms. This focus was selected, however, to avoid the
probable impact of a combined recognition and recol-
lection bias in disfavour of basic symptoms described
for clinical samples (Schultze-Lutter et al. 2010).
Implications
Within these minor constraints, the results of this
unique representative community study demonstrate
that the broad implementation of psychosis-risk cri-
teria, e.g. in primary care or counselling services, will
not result in pathologising common non-ill experiences
in young adults. Furthermore, the indicated clinical
relevance of both psychosis-risk symptoms and cri-
teria, in particular the combined presence of ultra-high
risk and basic symptoms, as well as their predominant
association with functional impairment, reinforce the
need to consider these symptoms in treatment plans.
Thus, beyond any potential risk of developing psych-
osis, clinicians should probe for psychosis-risk symp-
toms, especially in young adults and patients with a
positive family history of mental disorders and history
of trauma and/or of substance use. Greater insight into
the longitudinal relationship of psychosis-risk symp-
toms and criteria to the development of frank psych-
osis will be gained from future follow-ups.
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